Timing of arteriovenous fistula placement and medicare costs during dialysis initiation

American Journal of Nephrology

Volumn 35, Issue 6, 2012, Pages 498-508

  Solid, Craig A ^a   Carlin, Caroline ^b,c  

^a MINNEAPOLIS MEDICAL RESEARCH FOUNDATION   (United States)

^b Medica Research Institute   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Endogenous selection; Hemodialysis; Selection bias; Vascular access

Indexed keywords

AGED; ARTERIOVENOUS FISTULA; CATHETER; FEMALE; HEALTH CARE COST; HEMODIALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICARE; PRIORITY JOURNAL; REVIEW;

AGED; AGED, 80 AND OVER; ANASTOMOSIS, SURGICAL; ARTERIES; COMORBIDITY; FEMALE; HEALTH CARE COSTS; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MEDICARE; MODELS, ECONOMIC; PATIENT SELECTION; RENAL DIALYSIS; TIME FACTORS; UNITED STATES; VEINS;

EID: 84860806767     PISSN: 02508095     EISSN: 14219670     Source Type: Journal    
DOI: 10.1159/000338518     Document Type: Review

References (41)

1. Gilbertson DT, Liu J, Xue JL, Louis TA, Solid CA, Ebben JP, Collins AJ: Projecting the number of patients with end-stage renal disease in the United States to the year 2015. J Am Soc Nephrol 2005; 16: 3736-3741.
2. U.S. Renal Data System: USRDS 2010 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, ed 2010, Bethesda, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2010.
3. Spinowitz BS, Galler M, Golden RA, Rascoff JH, Schechter L, Held B, Charytan C: Subclavian vein stenosis as a complication of subclavian catheterization for hemodialysis. Arch Intern Med 1987; 147: 305-307.
4. Barrett N, Spencer S, McIvor J, Brown EA: Subclavian stenosis: a major complication of subclavian dialysis catheters. Nephrol Dial Transplant 1988; 3: 423-425.
5. National Kidney Foundation: An introduction to the kidneys and chronic kidney disease.2011. http://www.kidney.org/patients/ plu/plu-intro/pluo-9.cfm (accessed February 2, 2012).
6. Astor BC, Eustace JA, Powe NR, Klag MJ, Fink NE, Coresh J: Type of vascular access and survival among incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for ESRD (CHOICE) study. J Am Soc Nephrol 2005; 16: 1449-1455.
7. Perera GB, Mueller MP, Kubaska SM, Wilson SE, Lawrence PF, Fujitani RM: Superiority of autogenous arteriovenous hemodialysis access: maintenance of function with fewer secondary interventions. Ann Vasc Surg 2004; 18: 66-73.
8. Mehta S: Statistical summary of clinical results of vascular access procedures for hemodialysis; in Sommer BG, Henry ML (eds): Vascular Access for Hemodialysis - II. Chicago, W. L. Gore & Associates, 1991, pp 145- 157.
9. Eggers P, Milam R: Trends in vascular access procedures and expenditures in Medicare's ESRD program; Vascular Access for Hemodialysis - VII. Chicago, Gore, 2001, pp 133- 143.
10. Polkinghorne KR, McDonald SP, Atkins RC, Kerr PG: Vascular access and all-cause mortality: a propensity score analysis. J Am Soc Nephrol 2004; 15: 477-486.
11. Feldman HI, Held PJ, Hutchinson JT, Stoiber E, Hartigan MF, Berlin JA: Hemodialysis vascular access morbidity in the United States. Kidney Int 1993; 43: 1091-1096.
12. Nassar GM, Ayus JC: Infectious complications of the hemodialysis access. Kidney Int 2001; 60: 1-13.
13. Gulati S, Sahu KM, Avula S, Sharma RK, Ayyagiri A, Pandey CM: Role of vascular access as a risk factor for infections in hemodialysis. Ren Fail 2003; 25: 967-973.
14. Dhingra RK, Young EW, Hulbert-Shearon TE, Leavey SF, Port FK: Type of vascular access and mortality in U.S. hemodialysis patients. Kidney Int 2001; 60: 1443-1451.
15. Xue JL, Dahl D, Ebben JP, Collins AJ: The association of initial hemodialysis access type with mortality outcomes in elderly Medicare ESRD patients. Am J Kidney Dis 2003; 42: 1013-1019.
16. Schlieper G, Kruger T, Djuric Z, Damjanovic T, Markovic N, Schurgers LJ, Brandenburg VM, Westenfeld R, Dimkovic S, Ketteler M, Grootendorst DC, Dekker FW, Floege J, Dimkovic N: Vascular access calcification predicts mortality in hemodialysis patients. Kidney Int 2008; 74: 1582-1587.
17. Woods JD, Port FK: The impact of vascular access for haemodialysis on patient morbidity and mortality. Nephrol Dial Transplant 1997; 12: 657-659.
18. Ishani A, Collins AJ, Herzog CA, Foley RN: Septicemia, access and cardiovascular disease in dialysis patients: the USRDS Wave 2 study. Kidney Int 2005; 68: 311-318.
19. Raithatha A, McKane W, Kendray D, Evans C: Catheter access for hemodialysis defines higher mortality in late-presenting dialysis patients. Ren Fail 2010; 32: 1183-1188.
20. Lopez-Gomez JM, Portoles JM, Aljama P: Factors that condition the response to erythropoietin in patients on hemodialysis and their relation to mortality. Kidney Int 2008; 74(suppl 111):S75-S81.
21. Chand DH, Teo BW, Fatica RA, Brier M: Influence of vascular access type on outcome measures in patients on maintenance hemodialysis. Nephron Clin Pract 2008; 108:c91-c98.
22. Goicoechea M, Caramelo C, Rodriguez P, Verde E, Gruss E, Albalate M, Ortiz A, Casado S, Valderrabano F: Role of type of vascular access in erythropoietin and intravenous iron requirements in haemodialysis. Nephrol Dial Transplant 2001; 16: 2188-2193.
23. National Kidney Foundation: NKF K/DOQI guidelines: clinical practice guidelines and clinical practice recommendations, 2006 updates hemodialysis adequacy, peritoneal dialysis adequacy, vascular access. 2006. http:// www.kidney.org/PROFESSIONALS/kdoqi/ guideline-upHD-PD-VA/va-guide1.htm (accessed February 2, 2012).
24. Albers FJ: Causes of hemodialysis access failure. Adv Ren Replace Ther 1994; 1: 107-118.
25. Schon D, Blume SW, Niebauer K, Hollenbeak CS, de LG: Increasing the use of arteriovenous fistula in hemodialysis: economic benefits and economic barriers. Clin J Am Soc Nephrol 2007; 2: 268-276.
26. Wu LC, Lin MY, Hsieh CC, Chiu HC, Mau LW, Chiu YW, Chen HC, Hwang SJ: Planned creation of vascular access saves medical expenses for incident dialysis patients. Kaohsiung J Med Sci 2009; 25: 521-529.
27. The Cost Effectiveness of Alternative Types of Vascular Access and the Economic Cost of ESRD. Bethesda, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Disorders, 1995, pp 139-157.
28. Foley RN, Murray AM, Li S, Herzog CA, Mc- Bean AM, Eggers PW, Collins AJ: Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999. J Am Soc Nephrol 2005; 16: 489-495.
29. Heckman JJ: Sample selection bias as a specification error. Econometrica 1979; 47: 153-161.
30. Chiburis R, Lokshin M: Maximum likelihood and two-step estimation of an orderedprobit selection model. Stata J 2007; 7: 167-182.
31. Manning WG: The logged dependent variable, heteroscedasticity, and the retransformation problem. J Health Econ 1998; 17: 283-295.
32. Manning WG, Mullahy J: Estimating log models: to transform or not to transform? J Health Econ 2001; 20: 461-494.
33. Duan N: Smearing estimate: a nonparametric retransformation method. J Am Stat Assoc 1983; 383: 605-610.
34. Wasse H, Kutner N, Zhang R, Huang Y: Association of initial hemodialysis vascular access with patient-reported health status and quality of life. Clin J Am Soc Nephrol 2007; 2: 708-714.
35. U.S. Renal Data System: USRDS 2011 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. ed 2011. Bethesda, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2011.
36. O'Hare AM, Bertenthal D, Walter LC, Garg AX, Covinsky K, Kaufman JS, Rodriguez RA, Allon M: When to refer patients with chronic kidney disease for vascular access surgery: should age be a consideration? Kidney Int 2007; 71: 555-561.
37. Lopez-Vargas PA, Craig JC, Gallagher MP, Walker RG, Snelling PL, Pedagogos E, Gray NA, Divi MD, Gillies AH, Suranyi MG, Thein H, McDonald SP, Russell C, Polkinghorne KR: Barriers to timely arteriovenous creation: a study of providers and patients. Am J Kidney Dis 2011; 57: 873-882.
38. Schon D, Blume SW, Niebauer K, Hollenbeak CS, de Lissovoy G: Increasing the use of arteriovenous fistula in hemodialysis: economic benefits and economic barriers. Clin J Am Soc Nephrol 2007; 2: 268-276.
39. Xi W, MacNab J, Lok CE, Lee TC, Maya ID, Mokrzycki MH, Moist LM: Who should be referred for a fistula? A survey of nephrologists. Nephrol Dial Transplant 2010; 25: 2644-2651.
40. Lok CE, Allon M, Moist L, Oliver MJ, Shah H, Zimmerman D: Risk equation determining unsuccessful cannulation events and failure to maturation in arteriovenous fistulas (REDUCE FTM I). J Am Soc Nephrol 2006; 17: 3204-3212.
41. U.S. Renal Data System: USRDS 2008 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Bethesda, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2008.